Results 31 to 40 of about 8,289 (149)

Complement Inhibition in the Clinic: Are We Doing Enough to Protect Patients From Infection?

open access: yesEuropean Journal of Immunology, Volume 56, Issue 7, July 2026.
Excessive complement activation is implicated in a broad range of diseases. Therapeutic approaches targeting the complement cascade, from pathway‐selective inhibition to terminal blockade, can effectively control disease activity. However, increasing degrees of complement inhibition are associated with a heightened susceptibility to bacterial, viral ...
Serena Bettoni   +4 more
wiley   +1 more source

Compartment‐Specific Immune Remodeling of Renal Aging With C1q‐Associated Podocyte Activation

open access: yesThe FASEB Journal, Volume 40, Issue 11, 15 June 2026.
Aging repatterns the renal immune response in a compartment‐specific manner, distinct from chronic kidney disease (CKD) adaptation. Glomerular aging features C1q‐associated podocyte activation and macrophage engagement, whereas tubulointerstitial aging is marked by B‐cell aggregation and tertiary lymphoid structure expansion.
Ju‐Young Moon   +10 more
wiley   +1 more source

Schistosomal glomerulopathy and changes in the distribution of histological patterns of glomerular diseases in Bahia, Brazil

open access: yesMemorias do Instituto Oswaldo Cruz, 2011
Distinct patterns of glomerular lesions, including membranoproliferative glomerulonephritis and focal segmental glomerulosclerosis, are associated with infection by Schistosoma mansoni or Schistosoma japonicum.
Washington Luis Conrado dos-Santos   +3 more
doaj   +1 more source

Secondary membranoproliferative glomerulonephritis

open access: yesKidney International, 1995
A 37-year-old man was transferred to Brigham and Women's Hospital for evaluation of progressive renal failure. His medical history was notable for intravenous drug use and heavy ethanol consumption but he denied their use for the last 7 years. He had had at least one bout of alcoholic hepatitis, which was diagnosed about 8 years previously. The patient
openaire   +2 more sources

The Spectrum of Biopsy‐Proven Renal Diseases in Chinese Elderly Patients and Its Temporal Shift Over 20 Years: A Retrospective Cohort Study

open access: yesAGING MEDICINE, Volume 9, Issue 3, Page 258-264, June 2026.
This 20‐year retrospective study reveals a significant increase in renal biopsy utilization and a pivotal shift in biopsy‐proven renal disease among Chinese elderly patients. Secondary glomerular nephropathy (particularly diabetic nephropathy and hypertensive nephropathy) has surpassed primary glomerular nephropathy as the leading biopsy‐proven ...
Shasha Han   +4 more
wiley   +1 more source

Cardiac Angiosarcoma-Associated Membranoproliferative Glomerulonephropathy

open access: yesCase Reports in Medicine, 2011
Primary cardiac angiosarcoma is a rare cardiac tumor. The initial clinical course is often asymptomatic, and metastatic disease is present in a majority of affected patients at diagnosis.
Lokesh Shahani   +2 more
doaj   +1 more source

Primary membranoproliferative glomerulonephritis in Sfax, Tunisia: epidemiologic profile and prognostic factors

open access: yesThe Pan African Medical Journal, 2021
INTRODUCTION: Membranoproliferative glomerulonephritis (MPGN) is a rare kidney disease with a poor prognosis as 50% of patients attend the end stage renal failure after 10 years of follow up. Several factors have been described associated with poor renal
Ikram Agrebi   +6 more
doaj   +1 more source

Shifting From Systemic to Precision‐Targeted Complement Therapies: Opportunities and Hurdles

open access: yesEuropean Journal of Immunology, Volume 56, Issue 6, June 2026.
Complement therapeutics have expanded considerably, but systemic inhibitors remain limited by infection risks, breakthrough events, and loss of physiological functions. Emerging targeted approaches aim for organ‐, tissue‐, or cell‐specific modulation of complement activity, potentially offering greater precision while reducing treatment burden and ...
Marco Mannes   +2 more
wiley   +1 more source

Membranoproliferative Glomerulonephritis Associated with Nivolumab Therapy

open access: yesCase Reports in Nephrology, 2020
Nivolumab is an immune checkpoint inhibitor that targets programmed death-1 on T cells and is designed to amplify an immunologic reaction against cancer cells.
Jessica Cruz-Whitley   +3 more
doaj   +1 more source

Biomarkers for Early Detection of Diabetic Kidney Disease in Pediatric and Adolescent Populations: A Narrative Review

open access: yesHealth Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background Diabetic nephropathy is among the most critical long‐term complications linked to diabetes, substantially influencing both morbidity and mortality. Although it was once largely associated with adults, diabetic kidney disease (DKD) has now become a leading source of kidney complications among children worldwide.
Iran Malekzadeh   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy